立即 vs 延迟产后避孕器植入物放置后的母乳养:一个非劣质性随机对照试验
Jamie W Krashin1, Maritza Rivera-Montalvo2, Lawrence Leeman3
1Department of Obstetrics & Gynecology, University of New Mexico, Albuquerque, NM.
American journal of obstetrics and gynecology
|March 22, 2025
概括
与延迟安置相比,在产后立即安装etonogestrel植入物时,在8周继续母乳养方面没有显示出统计学上显著的差异. 然而,在母乳养或植入物延续的结果中没有观察到临床上显著的差异.
科学领域:
- 生殖健康 生殖健康
- 避孕药是一种避孕药,用于避孕.
- 母婴健康 母婴健康
背景情况:
- 哺乳和避孕对公众健康至关重要.
- 乙格斯特勒植入物是一种高效的,长效的避孕药,几乎没有禁忌.
- 之前的研究表明,立即安置对乳腺发育是安全的,但与延迟安置的直接比较缺乏.
研究的目的:
- 为了比较在产后8周继续母乳养的立即 (在24小时内) 和延迟 (至少2周) etonogestrel植入物放置之间的情况.
- 评估立即安置与延迟安置在继续母乳养方面的非劣势.
主要方法:
- 一个非劣等性随机对照试验,涉及150名产后参与者计划母乳养.
- 参与者被随机分配到24小时内或分娩后至少2周内安装etonogestrel植入物.
- 通过电子问卷追踪了母乳养状态和植入物使用情况,直到分娩后24周.
主要成果:
- 在每项方案分析中,77.4%的即时组和81.1%的延迟组报告了8周的母乳养,超过了非劣势差额.
- 在修改后的治疗意图分析中,母乳养率相似 (78.3%即时 vs 78.9%延迟),在非劣势区间内.
- 在24周植入植入的延续趋势是偏好立即安置 (96%) 而不是延迟安置 (85%),尽管在统计学上并不显著 (P=.08).
结论:
- 在立即和延迟的etonogestrel植入物放置之间,在母乳养或植入物延续结果中没有发现临床上显著的差异.
- 尽管主要结果超过了非劣势差额,但数据支持在任何期望的产后时间为哺乳期的个体提供乙格斯特勒植入物.
- 这些发现有助于证据基础,支持早期的避孕药植入在哺乳期的个体.
更多相关视频
05:04A Common Marmoset Model of Mother-Infant Intervention for Breastfeeding Disorders in the Presence of Paternal Inhibition and Maternal Neglect
Published on: September 22, 2023
357
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.3K
相关概念视频
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
